By coating biodegradable nanoparticles with macrophage membranes, scientists developed a targeted antifungal delivery platform that increased drug accumulation at infection sites and improved treatment efficacy in preclinical studies. The post Macrophage Membrane-Derived Nanoparticles Shows Potential Against Candida Infections appeared first on GEN – Genetic Engineering and Biotechnology News.
You may also like
This common pesticide may be quietly wiping out future...
Boehringer Ingelheim’s Jascayd approved by MHRA for...
Ipsen to acquire Memo Therapeutics in deal worth more...
GSK, Hansoh ADC extends survival in lung cancer study
ARPA-H puts $160M into bespoke drug therapies;...
Bausch + Lomb gives up on glaucoma eye drop hopeful...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.